These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 30224057)

  • 1. Atf3 induction is a therapeutic target for obesity and metabolic diseases.
    Kim S; Song NJ; Bahn G; Chang SH; Yun UJ; Ku JM; Jo DG; Park KW
    Biochem Biophys Res Commun; 2018 Oct; 504(4):903-908. PubMed ID: 30224057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating transcription factor 3 regulates immune and metabolic homeostasis.
    Rynes J; Donohoe CD; Frommolt P; Brodesser S; Jindra M; Uhlirova M
    Mol Cell Biol; 2012 Oct; 32(19):3949-62. PubMed ID: 22851689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying UCP1 dependent and independent adipocyte thermogenesis.
    Chang SH; Song NJ; Choi JH; Yun UJ; Park KW
    Obes Rev; 2019 Feb; 20(2):241-251. PubMed ID: 30450758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Phf16 and Pnpla3 as new adipogenic factors regulated by phytochemicals.
    Chang SH; Yun UJ; Choi JH; Kim S; Lee AR; Lee DH; Seo MJ; Panic V; Villanueva CJ; Song NJ; Park KW
    J Cell Biochem; 2019 Mar; 120(3):3599-3610. PubMed ID: 30272815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxyresveratrol Increases Energy Expenditure through Foxo3a-Mediated Ucp1 Induction in High-Fat-Diet-Induced Obese Mice.
    Choi JH; Song NJ; Lee AR; Lee DH; Seo MJ; Kim S; Chang SH; Yang DK; Hwang YJ; Hwang KA; Ha TS; Yun UJ; Park KW
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.
    Fang J; Ji YX; Zhang P; Cheng L; Chen Y; Chen J; Su Y; Cheng X; Zhang Y; Li T; Zhu X; Zhang XJ; Wei X
    Hepatology; 2020 May; 71(5):1592-1608. PubMed ID: 31529495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocyte browning and resistance to obesity in mice is induced by expression of ATF3.
    Cheng CF; Ku HC; Cheng JJ; Chao SW; Li HF; Lai PF; Chang CC; Don MJ; Chen HH; Lin H
    Commun Biol; 2019; 2():389. PubMed ID: 31667363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells.
    Shi Z; Zhang K; Chen T; Zhang Y; Du X; Zhao Y; Shao S; Zheng L; Han T; Hong W
    Cell Death Dis; 2020 Dec; 11(12):1066. PubMed ID: 33311456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc
    Wang L; Liu Y; Du T; Yang H; Lei L; Guo M; Ding HF; Zhang J; Wang H; Chen X; Yan C
    Cell Death Differ; 2020 Feb; 27(2):662-675. PubMed ID: 31273299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.
    Xu Y; Li Y; Jadhav K; Pan X; Zhu Y; Hu S; Chen S; Chen L; Tang Y; Wang HH; Yang L; Wang DQ; Yin L; Zhang Y
    Nat Metab; 2021 Jan; 3(1):59-74. PubMed ID: 33462514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial oxidative stress-induced transcript variants of ATF3 mediate lipotoxic brain microvascular injury.
    Nyunt T; Britton M; Wanichthanarak K; Budamagunta M; Voss JC; Wilson DW; Rutledge JC; Aung HH
    Free Radic Biol Med; 2019 Nov; 143():25-46. PubMed ID: 31356870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases.
    Glal D; Sudhakar JN; Lu HH; Liu MC; Chiang HY; Liu YC; Cheng CF; Shui JW
    Front Immunol; 2018; 9():2522. PubMed ID: 30455690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Synthesized Activating Transcription Factor 3 Inducer SW20.1 Suppresses Resistin-Induced Metabolic Syndrome.
    Tran TT; Huang WJ; Lin H; Chen HH
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PVAT in obesity-related cardiovascular disease through the buffering activity of ATF3.
    Li HF; Liu HT; Chen PY; Lin H; Tseng TL
    iScience; 2022 Dec; 25(12):105631. PubMed ID: 36458260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of the itaconate-mediated rescue of cellular metabolic stress.
    Sun DS; Chang HH
    Tzu Chi Med J; 2022; 34(2):134-138. PubMed ID: 35465285
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wu YL; Lin H; Li HF; Don MJ; King PC; Chen HH
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies.
    Jin X; Yang S; Lu J; Wu M
    Front Cardiovasc Med; 2021; 8():804214. PubMed ID: 35224026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
    Fu D; Wang C; Yu L; Yu R
    Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer.
    Ku HC; Cheng CF
    Front Endocrinol (Lausanne); 2020; 11():556. PubMed ID: 32922364
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.